Impact Factor
3.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.36
2,409 total citations
h5-index
38
h5 depth signal
Cited share
72.4%
771 of 1,065
Total citations
2,409
Citation footprint
Metric signal
2.60
External metric anchor
Self-citation
3.6%
87 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
1,427
United States
583
Japan
486
Italy
473
Germany
470
Citing Fields of Research
Hematology
3,072
Lymphomas
1,615
Immunology
373
Oncology
265
Auto-Inflammatory Disorders
156
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
13,616
Articles tracked across the journal lifetime
Indexed publication set
1,065
771 cited publications
Last 12 months
658
54.8 publications/month
Open access share
100.0%
658 OA publications in the last year
Leading citing country
China
1,427 citing publications
Leading citing field
Hematology
3,072 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v62n1,Feb. 1991-
v62n1,Feb. 1991-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Lymphomas
Issuing & Sponsoring Bodies
Contributor
Deutsche Gesellschaft für Hämatologie und Onkologie
Broad Categories
Hematology
Lymphomas
MeSH Descriptors
Hematologic Diseases
Hematology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
DOI 10.1007/s00277-026-07324-2
Open DOI
As2S2 restores erythroid maturation in sf3b1-deficient zebrafish by upregulating smad7
05
DOI 10.1007/s00277-026-07323-3
Open DOI
Evolving infectious epidemiology in acute myeloid leukemia in the contemporary era: a 13-year retrospective, single-center analysis of induction therapies
We evaluated the 13-year (2012–2025) evolution of infectious epidemiology in a Polish acute myeloid leukemia (AML) induction cohort, contextualizing these findings within shifting antimicrobial resistance (AMR), the SARS-CoV-2 pandemic, ...
06
DOI 10.1007/s00277-026-07321-5
Open DOI
Association of HLA-DRB1*12 with red cell alloimmunization in transfusion-dependent thalassemia
07
08
09
DOI 10.1007/s00277-026-07309-1
Open DOI
Management of pregnancy in women with transfusion-dependent β-thalassemia: An evidence-based narrative review with clinical recommendations
Transfusion-dependent β-thalassemia (TDT) is a severe hereditary hemoglobin disorder requiring lifelong regular blood transfusions, which inevitably result in iron overload and multiple organ complications. Advances in transfusion therap...
10
DOI 10.1007/s00277-026-07318-0
Open DOI
Hepatic adverse-event reporting after CAR T-cell therapy: a pharmacovigilance analysis of FAERS and Canada Vigilance
Hepatic adverse events after chimeric antigen receptor (CAR) T-cell therapy may reflect cytokine release syndrome (CRS), immune effector cell-associated haemophagocytic syndrome/haemophagocytic lymphohistiocytosis (IEC-HS/HLH), or immune...
Bibliographical & Catalog Notes
12 issues per year.
Title from cover.
Also available online.
Organ of Deutsche Gesellschaft für Hämatologie und Onkologie and other similar societies.
Continues: Blut.
Vol. 62, no. 1 (FEB 1991)19910322 Notice published Printed on acid-free paper